Status:
COMPLETED
Study in Subjects Suspected of Having CAD Undergoing VISIPAQUE-enhanced CCTA as Part of Their Routine Medical Care
Lead Sponsor:
GE Healthcare
Conditions:
Coronary Artery Disease (CAD)
Eligibility:
All Genders
18+ years
Brief Summary
To assess prognostic value of CCTA examination in subjects who undergo CCTA as part of their medical care when compared to a standard of truth, i.e. subject outcomes during each follow-up period.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- The subject is over 18 years old, exhibits chest pain syndrome and is scheduled to undergo a VISIPAQUE-enhanced CCTA examination for one of the following reasons:- Intermediate pre-test probability of CAD.
- An uninterruptible/equivocal stress test (exercise, perfusion, or stress echo).
Exclusion
Key Trial Info
Start Date :
September 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
885 Patients enrolled
Trial Details
Trial ID
NCT00783302
Start Date
September 1 2008
End Date
April 1 2011
Last Update
December 11 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GE Healthcare
Princeton, New Jersey, United States, 08540